Finance

Beta
Ask
Lists
NX1:ASX
Nexalis Therapeutics Ltd
A$0.020
0.00%
(0.00) 1D
Jun 12, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NX1...
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
5.06M
Avg. vol.
89.70K
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.02
EPS
-A$0.01
Shares outstanding
253.04M
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
5.06M
Avg. vol.
89.70K
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.02
EPS
-A$0.01
Shares outstanding
253.04M
News stories
From sources across the web
About Nexalis Therapeutics Ltd
CEO-
Employees-
Founded2016
Headquarters-
SectorMedical device
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
278.56K
278.56K
214.66K
214.66K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
503.06K
503.06K
376.83K
376.83K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.28K
153.28K
182.51K
182.51K
Operating expense
678.17K
678.17K
559.06K
559.06K
Total operating expenses
678.17K
678.17K
559.06K
559.06K
Operating income
-399.61K
-399.61K
-344.40K
-344.40K
Other non operating income
-
-
-
-
EBT including unusual items
-427.17K
-427.17K
-382.22K
-382.22K
EBT excluding unusual items
-427.17K
-427.17K
-382.22K
-382.22K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
21.83K
21.83K
-13.90K
-13.90K
Net income
-427.17K
-427.17K
-382.22K
-382.22K
Net profit margin
-153.35%
-153.35%
-178.06%
-178.06%
Earnings per share
-
-
-
-
Interest and investment income
-
-
2.87K
2.87K
Interest expense
-27.56K
-27.56K
-40.69K
-40.69K
Net interest expenses
-27.56K
-27.56K
-37.82K
-37.82K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more